Skip to main content

Release not found

This press release isn’t in the live store anymore. Open the original on the wire, or jump into the live feed.

Go to feed
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy · Eli Lilly — News Releases · PPN World